Tech Company Financing Transactions
Cellbyte Funding Round
On 11/18/2025, Cellbyte raised $2.8 million in Seed funding from Frontline Ventures, Pace Capital and Saras Capital.
Transaction Overview
Company Name
Announced On
11/18/2025
Transaction Type
Venture Equity
Amount
$2,750,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to triple its headcount and expand its engineering capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Munich, Undisclosed
Germany
Munich, Undisclosed
Germany
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Every pharmaceutical drug launch is a uniquely complex endeavour. Before patients can access novel treatments, pharmaceutical manufacturers need to carefully analyze gigabytes of messy, fragmented data, create thousands of pages of regulatory documents, determine global launch sequences, and so much more. Historically, this complexity has inevitably resulted in multiple years of necessary preparation. Our vision is to accelerate pharmaceutical drug launches. By automating repetitive workflows on top of our robust data foundation, we help pharmaceutical companies bring life-saving treatments to patients faster than ever before.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Daniel Moreira
Founder
Felix Steinbrenner
Browse more venture capital transactions:
Prev: 11/18/2025: Apono venture capital transaction
Next: 11/18/2025: TMT ID venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs